Quentin S. Blackford - 30 Mar 2022 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
Director
Signature
/s/ Quentin Blackford
Issuer symbol
AXGN
Transactions as of
30 Mar 2022
Net transactions value
$0
Form type
4
Filing time
01 Apr 2022, 16:55:16 UTC
Previous filing
07 Oct 2021
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Options Exercise $0 +3,036 +12% $0.000000 27,335 30 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Restricted Stock Units Options Exercise $0 -3,036 -100% $0.000000* 0 30 Mar 2022 Common Stock 3,036 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Quentin S. Blackford is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 This reflects the number of restricted stock units that became vested as of March 30, 2022.
F2 Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
F3 Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units. This grant was accelerated by Axogen's Board of Directors to vest upon departure.